{"disease":{"id":"adenocarcinoma-of-esophagogastric-junction","name":"adenocarcinoma of esophagogastric junction"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05419349","title":"Novel Staging Schemes for Siewert Type II Esophagogastric Junction Adenocarcinoma: A Real-World Data Cohort Study From SEER Database","phase":"","overall_status":"COMPLETED","enrollment_count":1819,"lead_sponsor_name":"Fujian Medical University Union Hospital","has_results":false},{"nct_id":"NCT04151524","title":"Classification of Adenocarcinoma of the Esophagogastric Junction","phase":"","overall_status":"UNKNOWN","enrollment_count":1658,"lead_sponsor_name":"St. James's Hospital, Ireland","has_results":false},{"nct_id":"NCT06277908","title":"Postoperative Morbidity and Mortality After Gastric Cancer Surgery","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"P. Herzen Moscow Oncology Research Institute","has_results":false},{"nct_id":"NCT05872685","title":"Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":314,"lead_sponsor_name":"Yu jiren","has_results":false},{"nct_id":"NCT07095699","title":"Intraoperative Margin Techniques for Esophagogastric Junction Adenocarcinoma: A Controlled Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":314,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04910789","title":"Transhiatal/Transabdominal Approach Compare With Thoracoabdominal Approach for Siewert II Adenocarcinoma of Esophagogastric Junction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":312,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT07441785","title":"Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"P. Herzen Moscow Oncology Research Institute","has_results":false},{"nct_id":"NCT06644352","title":"Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":236,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT06277921","title":"Morbidity and Mortality After Esophageal and Esophagogastric Junction Cancer Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"P. Herzen Moscow Oncology Research Institute","has_results":false},{"nct_id":"NCT05356520","title":"Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction","phase":"NA","overall_status":"RECRUITING","enrollment_count":212,"lead_sponsor_name":"Xijing Hospital of Digestive Diseases","has_results":false},{"nct_id":"NCT06347757","title":"A 3-Arm Study Comparing the Efficacy of Anti-Reflux Reconstruction Protocols After Laparoscopic Proximal Gastrectomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Northern Jiangsu People's Hospital","has_results":false},{"nct_id":"NCT03647540","title":"The Application of Fluorescence Laparoscopy in the Treatment of Adenocarcinoma of the Esophagogastric Junction","phase":"NA","overall_status":"UNKNOWN","enrollment_count":164,"lead_sponsor_name":"Dong Yang","has_results":false},{"nct_id":"NCT03416101","title":"Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival","phase":"","overall_status":"COMPLETED","enrollment_count":154,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT03045770","title":"mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT04423354","title":"A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG","phase":"NA","overall_status":"UNKNOWN","enrollment_count":94,"lead_sponsor_name":"Guangdong Provincial Hospital of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT05729646","title":"Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Yu jiren","has_results":false},{"nct_id":"NCT06222944","title":"Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":90,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT05163483","title":"Tucidinostat Plus PD-1 Inhibitor and Bevacizumab for Advanced Esophagus Cancer, AEG, Gastric Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":87,"lead_sponsor_name":"Ruihua Xu","has_results":false},{"nct_id":"NCT02287129","title":"Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Technical University of Munich","has_results":false},{"nct_id":"NCT03030937","title":"Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":74,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT03734913","title":"A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":65,"lead_sponsor_name":"Guangdong Zhongsheng Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06158919","title":"A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":58,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06681298","title":"A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36,"lead_sponsor_name":"xiaohua li","has_results":false},{"nct_id":"NCT05829213","title":"A Modified Esophagogastric Reconstruction Method After Laparoscopic Proximal Gastrectomy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT05715931","title":"Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Yu jiren","has_results":false},{"nct_id":"NCT05970627","title":"Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Yu jiren","has_results":false},{"nct_id":"NCT04813523","title":"Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT06300879","title":"A Prospective Study on Esophagogastrostomy by an Innovative Surgical Technique","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT06044311","title":"Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"Sakti Chakrabarti","has_results":false},{"nct_id":"NCT04891900","title":"TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT07406984","title":"Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Adenocarcinoma of Gastric/Esophagogastric Junction","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":18,"lead_sponsor_name":"Beijing Immunochina Medical Science & Technology Co., Ltd.","has_results":false},{"nct_id":"NCT03302403","title":"Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors","phase":"NA","overall_status":"UNKNOWN","enrollment_count":18,"lead_sponsor_name":"Kang YU","has_results":false}],"total":32},"guidelines":[],"source":"Drug Landscape verified database"}